Dementia Trials Ireland will advertise an annual seed funding call which will support early career researchers whose work directly aligns with the future trial development within DTI.
Funding proposals will be based on the following priorities: dementia in intellectual disability, dementia in nursing homes, palliative care in dementia, neuromodulation for Parkinson’s-related dementia/MCI:
- Development of Core Outcome Sets (COS)
- A priority setting partnership (PSP), supported by James Lind Alliance methodology
- Evidence synthesis that would support trial planning
Applications will be reviewed annually by the DTI Seed Funding Selection Committee.
The first seed funding bursary was awarded to Dr. Irina Kinchin in November 2022. Dr. Kinchin’s work will focus on setting research priorities for Lewy Body Dementia in Ireland.
Dr. Patrick Crowley was awarded the network’s 2023 Early Career Research Seed Funding award. Dr. Crowley will be looking at the relationship between sleep and cognitive impairment, and analysing whether reducing sleep disturbance can slow cognitive decline in people with mild cognitive impairment/mild dementia.
Dr. Eliza Georgiou, is the 2024/5 recipient of DTI’s ECR Seed Funding Award. Dr. Georgiou’s research will focus on assessing the feasibility of introducing disease-modifying therapies (DMTs) for Alzheimer’s disease in Ireland. The study will address equity of access, infrastructure requirements, and logistical challenges in public and private healthcare settings.
We envisage the next annual funding call to be announced in May 2026.